Proteomics reveals acute pro-inflammatory and protective responses in rat Kupffer cells and hepatocytes after chemical initiation of liver cancer and after LPS and IL-6

Proteomics - Clinical Applications

Volumn 3, Issue 8, 2009, Pages 947-967

  Lorenz, Olga ^a   Parzefall, Wolfram ^a   Kainzbauer, Eveline ^a   Wimmer, Heldge ^a   Grasl Kraupp, Bettina ^a   Gerner, Christopher ^a   Schulte Hermannn, Rolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hepatocarcinogenesis; Hepatocytes; Inflammation; Kupffer cells; N nitrosomorpholine

Indexed keywords

ACUTE PHASE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITROSOMORPHOLINE; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; KUPFFER CELL; LIQUID CHROMATOGRAPHY; LIVER CANCER; LIVER CELL; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; SYNTHESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

RATTUS;

EID: 70350221826     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800173     Document Type: Article

References (91)

1. Bosch, F. X., Ribes, J., Cleries, R., Diaz, M., Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2005, 9, 191-211, v.
2. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
3. Seitz, H. K., Stickel, F., Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol. Chem. 2006, 387, 349-360.
4. Balkwill, F., Coussens, L. M., Cancer: an inflammatory link. Nature 2004, 431, 405-406.
5. Coussens, L. M., Werb, Z., Inflammation and cancer. Nature 2002, 420, 860-867.
6. de Visser, K. E., Coussens, L. M., The inflammatory tumor microenvironment and its impact on cancer development. Contrib. Microbiol. 2006, 13, 118-137.
7. Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., Harris, C. C., TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 2007, 26, 2166-2176.
8. Bruix, J., Llovet, J. M., Hepatitis B virus and hepatocellular carcinoma. J. Hepatol. 2003, 39, S59-S63.
9. Iredale, J. P., Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 2007, 117, 539-548.
10. Levrero, M., Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 2006, 25, 3834-3847.
11. Moore, M. A., Kitagawa, T., Hepatocarcinogenesis in the rat: the effect of promoters and carcinogens in vivo and in vitro. Int. Rev. Cytol. 1986, 101, 125-173.
12. Nam, S. W., Park, J. Y., Ramasamy, A., Shevade, S. et al., Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005, 42, 809-818.
13. Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., Loeb, L. A., Environmental and chemical carcinogenesis. Semin. Cancer Biol. 2004, 14, 473-486.
14. Dini, L., Pagliara, P., Carla, E. C., Phagocytosis of apoptotic cells by liver: a morphological study. Microsc. Res. Tech. 2002, 57, 530-540.
15. Scaffidi, P., Misteli, T., Bianchi, M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418, 191-195.
16. Ferre, N., Claria, J., New insights into the regulation of liver inflammation and oxidative stress. Mini Rev. Med. Chem. 2006, 6, 1321-1330.
17. Gregory, S. H., Wing, E. J., Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J. Leukoc. Biol. 2002, 72, 239-248.
18. Kolios, G., Valatas, V., Kouroumalis, E., Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol. 2006, 12, 7413-7420.
19. Parker, G. A., Picut, C. A., Liver immunobiology. Toxicol. Pathol. 2005, 33, 52-62.
20. Teufelhofer, O., Parzefall, W., Kainzbauer, E., Ferk, F. et al., Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice. Carcinogenesis 2005, 26, 319-329.
21. Grasl-Kraupp, B., Luebeck, G., Wagner, A., Low-Baselli, A. et al., Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis 2000, 21, 1411-1421.
22. Drucker, C., Parzefall, W., Teufelhofer, O., Grusch, M. et al., Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis. Carcinogenesis 2006, 27, 152-161.
23. Weber, E., Bannasch, P., Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine. Carcinogenesis 1994, 15, 1219-1226.
24. Su, Q., Bannasch, P., Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol. Pathol. 2003, 31, 126-133.
25. Pitot, H. C., Pathways of progression in hepatocarcinogenesis. Lancet 2001, 358, 859-860.
26. Gerner, C., Vejda, S., Gelbmann, D., Bayer, E. et al., Concomitant determination of absolute values of cellular protein amounts, synthesis rates, and turnover rates by quantitative proteome profiling. Mol. Cell. Proteomics 2002, 1, 528-537.
27. Teufelhofer, O., Parzefall, W., Elbling, L., Kainzbauer, E. et al., Divide and conquer: rat liver tissue proteomics based on the analysis of purified constituents. Electrophoresis 2006, 27, 4112-4120.
28. Traxler, E., Bayer, E., Stockl, J., Mohr, T. et al., Towards a standardized human proteome database: quantitative proteome profiling of living cells. Proteomics 2004, 4, 1314-1323.
29. Friedman, S. L., Roll, F. J., Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal. Biochem. 1987, 161, 207-218.
30. Smedsrod, B., Pertoft, H., Eggertsen, G., Sundstrom, C., Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tissue Res. 1985, 241, 639-649.
31. Parzefall, W., Berger, W., Kainzbauer, E., Teufelhofer, O. et al., Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis 2001, 22, 519-523.
32. Gundacker, N., Bayer, E., Traxler, E., Zwickl, H. et al., Knowledge-based proteome profiling: considering identified proteins to evaluate separation efficiency by 2-D PAGE. Electrophoresis 2006, 27, 2712-2721.
33. Rabilloud, T., Strub, J. M., Luche, S., van Dorsselaer, A., Lunardi, J., A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 2001, 1, 699-704.
34. Zwickl, H., Traxler, E., Staettner, S., Parzefall, W. et al., A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005, 26, 2779-2785.
35. Fella, K., Gluckmann, M., Hellmann, J., Karas, M. et al., Use of two-dimensional gel electrophoresis in predictive toxicology: identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 2005, 5, 1914-1927.
36. Yamamoto, T., Kikkawa, R., Yamada, H., Horii, I., Investigation of proteomic biomarkers in in vivo hepatotoxicity study of rat liver: toxicity differentiation in hepatotoxicants. J. Toxicol. Sci. 2006, 31, 49-60.
37. Mbeunkui, F., Fodstad, O., Pannell, L. K., Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J. Proteome Res. 2006, 5, 899-906.
38. Bonin-Debs, A. L., Boche, I., Gille, H., Brinkmann, U., Development of secreted proteins as biotherapeutic agents. Exp. Opin. Biol. Ther. 2004, 4, 551-558.
39. Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., Mazur, M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160, 1-40.
40. Rhee, S. G., Chae, H. Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38, 1543-1552.
41. Nakamura, H., Thioredoxin and its related molecules: update 2005. Antioxid. Redox Signal. 2005, 7, 823-828.
42. Nordberg, J., Arner, E. S., Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31, 1287-1312.
43. Kuo, W. H., Chiang, W. L., Yang, S. F., Yeh, K. T. et al., The differential expression of cytosolic carbonic anhydrase in human hepatocellular carcinoma. Life Sci. 2003, 73, 2211-2223.
44. R.ais.anen, S. R., Lehenkari, P., Tasanen, M., Rahkila, P. et al., Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J. 1999, 13, 513-522.
45. Nappi, A. J., Vass, E., Hydroxyl radical formation via ironmediated Fenton chemistry is inhibited by methylated catechols. Biochim. Biophys. Acta 1998, 1425, 159-167.
46. Pool-Zobel, B., Veeriah, S., Bohmer, F. D., Modulation of xenobiotic metabolising enzymes by anticarcinogens - focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat. Res. 2005, 591, 74-92.
47. Salinas, A. E., Wong, M. G., Glutathione S-transferases - a review. Curr. Med. Chem. 1999, 6, 279-309.
48. Anderson, M. E., Glutathione: an overview of biosynthesis and modulation. Chem. Biol. Interact. 1998, 111- 112, 1-14.
49. Njalsson, R., Norgren, S., Physiological and pathological aspects of GSH metabolism. Acta Paediatr. 2005, 94, 132-137.
50. Garrido, C., Brunet, M., Didelot, C., Zermati, Y. et al., Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006, 5, 2592-2601.
51. Mishra, S., Murphy, L. C., Nyomba, B. L., Murphy, L. J., Prohibitin: a potential target for new therapeutics. Trends Mol. Med. 2005, 11, 192-197.
52. Grune, T., Reinheckel, T., Li, R., North, J. A., Davies, K. J., Proteasome-dependent turnover of protein disulfide isomerase in oxidatively stressed cells. Arch. Biochem. Biophys. 2002, 397, 407-413.
53. Emadali, A., Muscatelli-Groux, B., Delom, F., Jenna, S. et al., Proteomic analysis of ischemia-reperfusion injury upon human liver transplantation reveals the protective role of IQGAP1. Mol. Cell. Proteomics 2006, 5, 1300-1313.
54. Tsuruo, T., Naito, M., Tomida, A., Fujita, N. et al., Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 2003, 94, 15-21.
55. Baryshev, M., Sargsyan, E., Mkrtchian, S., ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem. Biophys. Res. Commun. 2006, 340, 617-624.
56. Cheretis, C., Dietrich, F., Chatzistamou, I., Politi, K. et al., Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma. Am. J. Dermatopathol. 2006, 28, 410-412.
57. Castell, J. V., Gomez-Lechon, M. J., David, M., Fabra, R. et al., Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990, 12, 1179-1186.
58. Kushner, I., Rzewnicki, D. L., The acute phase response: general aspects. Baillieres Clin. Rheumatol. 1994, 8, 513-530.
59. Tilg, H., Dinarello, C. A., Mier, J. W., IL-6 and APPs: antiinflammatory and immunosuppressive mediators. Immunol. Today 1997, 18, 428-432.
60. Streetz, K. L., Wustefeld, T., Klein, C., Manns, M. P., Trautwein, C., Mediators of inflammation and acute phase response in the liver. Cell. Mol. Biol. (Noisy-le-grand) 2001, 47, 661-673.
61. Camargo, C. A., Jr., Madden, J. F., Gao, W., Selvan, R. S., Clavien, P. A., Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997, 26, 1513-1520.
62. Taub, R., Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5, 836-847.
63. Petersen, A. M., Pedersen, B. K., The anti-inflammatory effect of exercise. J. Appl. Physiol. 2005, 98, 1154-1162.
64. Fausto, N., Involvement of the innate immune system in liver regeneration and injury. J. Hepatol. 2006, 45, 347-349.
65. Kerr, R., Stirling, D., Ludlam, C. A., Interleukin 6 and haemostasis. Br. J. Haematol. 2001, 115, 3-12.
66. Robinson, S. C., Coussens, L. M., Soluble mediators of inflammation during tumor development. Adv. Cancer Res. 2005, 93, 159-187.
67. Singh, A., Jayaraman, A., Hahn, J., Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes. Biotechnol. Bioeng. 2006, 95, 850-862.
68. Kaysen, G. A., Don, B. R., Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int. Suppl. 2003, S94-S97.
69. Kopitar-Jerala, N., The role of cystatins in cells of the immune system. FEBS Lett. 2006, 580, 6295-6301.
70. Kos, J., Sekirnik, A., Kopitar, G., Cimerman, N. et al., Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br. J. Cancer 2001, 85, 1193-1200.
71. Thurmond, R. L., Sun, S., Karlsson, L., Edwards, J. P., Cathepsin S inhibitors as novel immunomodulators. Curr. Opin. Investig. Drugs 2005, 6, 473-482.
72. Dobrovolskaia, M. A., Vogel, S. N., Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 2002, 4, 903-914.
73. Nguyen, T., Sherratt, P. J., Pickett, C. B., Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 233-260.
74. Mannaioni, P. F., Vannacci, A., Masini, E., Carbon monoxide: the bad and the good side of the coin, from neuronal death to anti-inflammatory activity. Inflamm. Res. 2006, 55, 261-273.
75. Hirsch, J., Hansen, K. C., Choi, S., Noh, J. et al., Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol. Cell. Proteomics 2006, 5, 979-986.
76. Haller, O., Kochs, G., Weber, F., The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344, 119-130.
77. Driscoll, K. E., TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol. Lett. 2000, 112-113, 177-183.
78. Kawaguchi, M., Adachi, M., Oda, N., Kokubu, F., Huang, S. K., IL-17 cytokine family. J. Allergy Clin. Immunol. 2004, 114, 1265-1273; quiz 1274.
79. Wolpe, S. D., Cerami, A., Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 1989, 3, 2565-2573.
80. Rudensky, A., Beers, C., Lysosomal cysteine proteases and antigen presentation. Ernst Schering Res. Found. Workshop 2006, 56 81-95.
81. Tani, K., Ogushi, F., Shimizu, T., Sone, S., Protease-induced leukocyte chemotaxis and activation: roles in host defense and inflammation. J. Med. Invest. 2001, 48, 133-141.
82. Lasker, M. V., Nair, S. K., Intracellular TLR signaling: a structural perspective on human disease. J. Immunol. 2006, 177, 11-16.
83. Schwabe, R. F., Seki, E., Brenner, D. A., Toll-like receptor signaling in the liver. Gastroenterology 2006, 130, 1886-1900.
84. Su, G. L., Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283, G256-G265.
85. Bulera, S. J., Eddy, S. M., Ferguson, E., Jatkoe, T. A. et al., RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 2001, 33, 1239-1258.
86. Burcham, P. C., Molecular basis for adaptive responses during chemically induced hepatotoxicity. Toxicol. Sci. 2006, 89, 349-351.
87. Vascotto, C., Cesaratto, L., D'Ambrosio, C., Scaloni, A. et al., Proteomic analysis of liver tissues subjected to early ischemia/ reperfusion injury during human orthotopic liver transplantation. Proteomics 2006, 6, 3455-3465.
88. Loeppky, R. N., Fuchs, A., Janzowski, C., Humberd, C. et al., Probing the mechanism of the carcinogenic activation of N-nitrosodiethanolamine with deuterium isotope effects: in vivo induction of DNA single-strand breaks and related in vitro assays. Chem. Res. Toxicol. 1998, 11, 1556-1566.
89. Kawanishi, S., Hiraku, Y., Pinlaor, S., Ma, N., Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 2006, 387, 365-372.
90. Grasl-Kraupp, B., Bursch, W., Ruttkay-Nedecky, B., Wagner, A. et al., Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. USA 1994, 91, 9995-9999.
91. Grasl-Kraupp, B., Ruttkay-Nedecky, B., M. ullauer, L., Taper, H. et al., Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 1997, 25, 906-912.